Cargando…
Survivin expression and serum levels in pancreatic cancer
BACKGROUND: Survivin, an inhibitor of apoptosis, is overexpressed in pancreatic ductal adenocarcinoma (PDAC). Its expression is known to be associated with poor clinical outcome. However, to our knowledge, there has been no study to characterize its usefulness as a serum marker for human pancreatic...
Autores principales: | Dong, He, Qian, Dongmeng, Wang, Yaqiu, Meng, Lingsheng, Chen, Dong, Ji, Xiangyu, Feng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469100/ https://www.ncbi.nlm.nih.gov/pubmed/26016480 http://dx.doi.org/10.1186/s12957-015-0605-7 |
Ejemplares similares
-
Survivin expression and its clinical significance in pancreatic cancer
por: Lee, Myung Ah, et al.
Publicado: (2005) -
Survivin and caspases serum protein levels and survivin variants mRNA expression in sepsis
por: Miliaraki, Marianna, et al.
Publicado: (2021) -
Is the serum level of survivin, an antiapoptotic protein, a potential predictive and prognostic biomarker in metastatic pancreatic cancer?
por: Demirci, Nebi Serkan, et al.
Publicado: (2023) -
Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells
por: Konopka, Krystyna, et al.
Publicado: (2008) -
Survivin as a Radioresistance Factor in Pancreatic Cancer
por: Asanuma, Koichi, et al.
Publicado: (2000)